Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has received partial relief from a US court in a litigation alleging delay by the company in launching three generic drugs in the American market. The company is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (District of Massachusetts), alleging a delay in the market entry for three generic drugs -- Valganciclovir, Valsartan and Esomeprazole.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.